Acadia Pharmaceuticals | ACAD - Capitalisation Boursière

Prix De L'Action
21.85
Variation Quotidienne
-0.60 -2.67%
Mensuellement
-1.58%
Annuel
46.55%
Q2 Prévisions
21.49




Capitalisation Boursière Changement Date
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
ALKERMES USD 4.62B 333M 2025-12
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Cara Therapeutics USD 366M 338M 2025-09
Corcept Therapeutics USD 4.32B 654M 2026-03
Cytokinetics USD 7.77B 1.19B 2025-12
Eisai JPY 1.31T 140.95B 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Incyte USD 18.73B 660M 2026-03
J&J USD 579.15B 78.91B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Neurocrine Biosciences USD 14.14B 218M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Prothena USD 514M 11M 2025-12
PTC Therapeutics USD 6.1B 1.22B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12